<DOC>
	<DOC>NCT00914303</DOC>
	<brief_summary>The aims of the study are to assess the safety, tolerability and pharmacokinetics of ER tablets of AZD3241 following multiple ascending doses administered to healthy male and female subjects including the effect of food.</brief_summary>
	<brief_title>Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241</brief_title>
	<detailed_description />
	<criteria>Healthy male and female subjects 3065 years Body Mass Index (BMI) between 18 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg History of any clinically significant disease or disorder History or presence of gastrointestinal, hepatic or renal disease or any other condition known to interfere with absorption, distribution, metabolism or excretion of drugs Previous history of frequent presyncope or syncope</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>Healthy volunteer study</keyword>
</DOC>